Cargando…

Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications

OBJECTIVE: To evaluate the cost-effectiveness of a genetic testing policy for HNF1A-, HNF4A-, and GCK-MODY in a hypothetical cohort of type 2 diabetic patients 25–40 years old with a MODY prevalence of 2%. RESEARCH DESIGN AND METHODS: We used a simulation model of type 2 diabetes complications based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naylor, Rochelle N., John, Priya M., Winn, Aaron N., Carmody, David, Greeley, Siri Atma W., Philipson, Louis H., Bell, Graeme I., Huang, Elbert S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Epidemiology/Health Services Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867988/ https://www.ncbi.nlm.nih.gov/pubmed/24026547 http://dx.doi.org/10.2337/dc13-0410

Ejemplares similares

Genetics and pathophysiology of neonatal diabetes mellitus
por: Naylor, Rochelle N, et al.
Publicado: (2011)

The Cost-Effectiveness of Personalized Genetic Medicine: The case of genetic testing in neonatal diabetes
por: Greeley, Siri Atma W., et al.
Publicado: (2011)

Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2)
por: Gregory, Justin M., et al.
Publicado: (2019)

Diabetes Presentation in Infancy: High Risk of Diabetic Ketoacidosis
por: Letourneau, Lisa R., et al.
Publicado: (2017)

SAT-129 Examining the Role of Genetic Testing in Early Onset Diabetes Occurring After 6 Months of Age
por: McCauley, Mary, et al.
Publicado: (2019)

SUN-143 Does a Monogenic Diabetes Diagnosis Impact Quality of Life?
por: Harris, Anastasia, et al.
Publicado: (2019)

Early Intensive Insulin Use May Preserve β-Cell Function in Neonatal Diabetes Due to Mutations in the Proinsulin Gene
por: Letourneau, Lisa R., et al.
Publicado: (2017)

SAT083 Comparing Grit, Anxiety, And Social Responsiveness In KCNJ11-NDM And Their Sibling Controls
por: Desai, Jui, et al.
Publicado: (2023)

Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry
por: Bowden, Tiana L., et al.
Publicado: (2021)

MON-009 The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing
por: GoodSmith, Matthew, et al.
Publicado: (2019)

Role of Noninsulin Therapies Alone or in Combination in Chromosome 6q24-Related Transient Neonatal Diabetes: Sulfonylurea Improves but Does Not Always Normalize Insulin Secretion
por: Carmody, David, et al.
Publicado: (2015)

Inheritance of Mildly Activating ABCC8 Mutation From a Mother With MODY Causes Permanent Neonatal Diabetes Mellitus (NDM) in Two Siblings Who Also Carry a Second Inactivating Mutation: Genetic Testing Allows for Improved Treatment With Sulfonylureas (SU)
por: Salguero Bermonth, Maria Victoria, et al.
Publicado: (2021)

Racial/Ethnic Differences in Dementia Risk Among Older Type 2 Diabetic Patients: The Diabetes and Aging Study
por: Mayeda, Elizabeth R., et al.
Publicado: (2014)

Cost and Cost-effectiveness of Large-scale Screening for Type 1 Diabetes in Colorado
por: McQueen, R. Brett, et al.
Publicado: (2020)

Incidence of Remission in Adults With Type 2 Diabetes: The Diabetes & Aging Study
por: Karter, Andrew J., et al.
Publicado: (2014)

Editorial: Advancements and challenges in cost and resource allocation: 2022
por: Hafidz, Firdaus, et al.
Publicado: (2023)

Acute Recurrent Pancreatitis in a Child With INS-Related Monogenic Diabetes and a Heterozygous Pathogenic CFTR Mutation
por: Son, Rachel G, et al.
Publicado: (2022)

Developing a knowledge translation program for health practitioners: Allied Health Translating Research into Practice
por: Young, Adrienne M., et al.
Publicado: (2023)

The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study)
por: Laiteerapong, Neda, et al.
Publicado: (2019)

Precision diabetes: Lessons learned from maturity‐onset diabetes of the young (MODY)
por: Tosur, Mustafa, et al.
Publicado: (2022)

Tooth Discoloration in Patients With Neonatal Diabetes After Transfer Onto Glibenclamide: A previously unreported side effect
por: Kumaraguru, Janani, et al.
Publicado: (2009)

Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes
por: Dalgin, Gokhan, et al.
Publicado: (2021)

LBODP084 Bilateral Cataracts In A 15-year-old Girl With New-onset Type 1 Diabetes Mellitus
por: Gunaratne, Naiomi C, et al.
Publicado: (2022)

Nationally Representative Medical Costs of Diabetes by Time Since Diagnosis
por: Trogdon, Justin G., et al.
Publicado: (2008)

Developing priorities to achieve health equity through diabetes translation research: a concept mapping study
por: Phad, Allison, et al.
Publicado: (2019)

Translating evidence-based knowledge objects into practice
por: Scheuer, John Damm
Publicado: (2023)

Editorial: Opportunity costs in health care: cost-effectiveness thresholds and beyond
por: Sampson, Chris, et al.
Publicado: (2023)

The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes
por: Lee, Alexandra K., et al.
Publicado: (2018)

Effect of periodontal treatment on diabetes-related healthcare costs: a retrospective study
por: Smits, Kirsten P J, et al.
Publicado: (2020)

Socioeconomic Disparities in Weight and Behavioral Outcomes Among American Indian and Alaska Native Participants of a Translational Lifestyle Intervention Project
por: Jiang, Luohua, et al.
Publicado: (2015)

Association of the Diabetes Health Plan with emergency room and inpatient hospital utilization: a Natural Experiment for Translation in Diabetes (NEXT-D) Study
por: Moin, Tannaz, et al.
Publicado: (2021)

Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data
por: Leal, Jose, et al.
Publicado: (2020)

Direct costs in impaired glucose regulation: results from the population-based Heinz Nixdorf Recall study
por: Bächle, C, et al.
Publicado: (2016)

Evaluation of AUSDRISK as a screening tool for lifestyle modification programs: international implications for policy and cost-effectiveness
por: Malo, Jonathan A, et al.
Publicado: (2015)

Health Care Use and Costs Associated With Use of a Health Club Membership Benefit in Older Adults with Diabetes
por: Nguyen, Huong Q., et al.
Publicado: (2008)

Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus
por: Oyagüez, Itziar, et al.
Publicado: (2020)

Performance and costs of multiple screening strategies for type 2 diabetes: two population-based studies in Shanghai, China
por: Li, Yanyun, et al.
Publicado: (2020)

Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs
por: Schwab, Phil, et al.
Publicado: (2016)

Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015
por: Jodar, Esteban, et al.
Publicado: (2020)

Designing healthcare for human use: Human factors and practical considerations for the translational process
por: Edwards III, G. Franklin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qidebdschvlr0k8qmgsfb3scpp